A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like ...

New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the ...

STOCKHOLM, SE / ACCESSWIRE / January 21, 2025 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

Behavioral and Cognitive Improvement: By acting on brain regions related to appetite and addiction, these drugs not only ...

RELATED: Doctor Says Ozempic Raises Certain Health Risks by Up to 900%. Per the study, weight-loss drugs can lower the risk for 42 health conditions, while also raising someone’s risk of developing 19 ...

A study by Washington University School of Medicine and the VA St. Louis Health Care System has found that GLP-1 drugs can ...

Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...

Scientists have come up with a drug that is a potential candidate for tackling memory deficits in the early stages of the disease in rodents. Research shows that the drug activates the cannabinoid ...

Microglia, the brain’s immune cells, play vital roles in clearing toxins and maintaining neuronal health but can also ...

Learn more about a new study claiming that GLP-1s could be used to treat cognitive conditions like dementia, but may pose a ...